Streamline Health Solutions, Inc. (STRM) Cash Flow Statement
Where STRM’s cash came from and went, FY2025
January 31, 2025 · U.S. dollars- Cash from operations
- −$1.5M
- Capital expenditures
- $858,000 4.8% of revenue
- Free cash flow
- −$2.4M −13.3% margin
- Returned to shareholders
- —
- Change in cash
- −$1.0M cash at year-end $2.2M
Cash from operations
−$1.5M
Capital expenditures
−$858,000
Investments (net)
−$858,000
Acquisitions & other
+$858,000
Shares issued
+$100,000
Other financing
+$1.3M
Change in cash
−$1.0M
Drawn to scale: where the cash came from and how it was used. Hover for values.
STRM operating cash flow, capex and free cash flow
Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)
STRM cash flow trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $5.9MFY2016 | −$1.5MFY2025 | — | |
| Capital expenditures | $518,254FY2016 | $858,000FY2025 | +5.8%/yr | |
| Free cash flow | $5.4MFY2016 | −$2.4MFY2025 | — | |
| Free cash flow margin | 18.9%FY2016 | −13.3%FY2025 | −32.2 pts | |
| Stock-based compensation | $2.4MFY2016 | $2.0MFY2025 | −2.1%/yr | |
| Dividends paid | $0FY2016 | $3.9MFY2020 | — | |
| Share buybacks (net) | $0FY2016 | $0FY2023 | — | |
| Capex / revenue | 1.8%FY2016 | 4.8%FY2025 | +3.0 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
STRM cash flow by activity
OperatingInvestingFinancingChange in cash
STRM net income vs operating cash flow
Net incomeOperating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
STRM cash flow statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$10.2M | −$18.7M | −$11.4M | −$6.9M | −$4.8M | −$2.9M | −$5.9M | −$3.1M | −$5.2M | −$4.3M |
| Depreciation & amortization | $4.9M | $4.3M | $4.3M | $3.7M | $2.6M | $2.1M | $2.5M | $4.0M | $5.2M | $5.7M |
| Stock-based compensation | $2.0M | $2.1M | $1.7M | $2.2M | $1.4M | $934,000 | $629,000 | $1.1M | $1.8M | $2.4M |
| Change in working capital | $1.1M | $1.3M | −$1.9M | $1.1M | −$1.5M | −$721,000 | −$1.2M | −$680,671 | −$976,945 | $3.4M |
| Other non-cash items | $752,000 | $8.7M | $127,000 | −$3.6M | −$3.4M | $493,000 | $5.3M | $652,952 | $143,072 | −$1.3M |
| Cash from operating activities | −$1.5M | −$2.2M | −$7.1M | −$3.5M | −$5.8M | −$8,000 | $1.4M | $2.0M | $1.0M | $5.9M |
| Investing activities | ||||||||||
| Capital expenditures | −$858,000 | −$1.6M | −$1.9M | −$1.5M | −$1.8M | −$3.4M | −$3.0M | −$1.9M | −$2.5M | −$518,254 |
| Investments (net) | −$858,000 | −$1.6M | −$1.9M | −$13.2M | $9.5M | −$3.4M | −$3.0M | −$1.9M | −$1.9M | — |
| Acquisitions & other investing | $858,000 | $1.6M | $1.9M | $1.5M | $1.8M | $3.4M | $3.0M | $1.9M | $2.5M | $0 |
| Cash from investing activities | −$858,000 | −$1.6M | −$1.9M | −$13.2M | $9.5M | −$3.4M | −$3.0M | −$1.9M | −$1.9M | −$518,254 |
| Financing activities | ||||||||||
| Dividends paid | — | — | — | — | — | −$3.9M | — | $0 | $0 | $0 |
| Share repurchases & issuance (net) | — | — | $8.3M | −$1.3M | −$1.3M | −$5.8M | $44,000 | $44,513 | $26,122 | $276,000 |
| Net borrowing (repayment) | — | — | −$270,000 | $10.0M | −$1.7M | −$4.4M | −$682,000 | −$1.2M | −$3.4M | −$2.3M |
| Shares issued | $100,000 | $0 | $8.3M | $16.1M | $0 | $9.7M | $0 | $0 | $0 | $0 |
| Other financing | $1.3M | $428,000 | −$10.5M | −$638,000 | $49,000 | $7.1M | $0 | $0 | $0 | $39 |
| Cash from financing activities | $1.4M | $428,000 | $5.8M | $24.1M | −$2.9M | $2.7M | −$638,000 | −$1.2M | −$3.4M | −$2.0M |
| Summary | ||||||||||
| Net change in cash | −$1.0M | −$3.4M | −$3.3M | $7.5M | $760,000 | −$727,000 | −$2.2M | −$1.0M | −$4.2M | $3.4M |
| Cash at end of period | $2.2M | $3.2M | $6.6M | $9.9M | $2.4M | $1.6M | $2.4M | $4.6M | $5.7M | $9.9M |
| Free cash flow | −$2.4M | −$3.8M | −$9.1M | −$5.0M | −$7.6M | −$3.4M | −$1.6M | $146,108 | −$1.5M | $5.4M |
| Free cash flow margin | −13.3% | −17.0% | −36.5% | −28.8% | −66.9% | −16.5% | −7.3% | 0.6% | −5.5% | 18.9% |
| Capex / revenue | 4.8% | 7.2% | 7.8% | 8.6% | 16.1% | 16.4% | 13.5% | 7.7% | 9.2% | 1.8% |
| Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | Jul '23 | Apr '23 | Jan '23 | Oct '22 | Jul '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$1.6M | −$2.1M | −$2.5M | −$2.8M | −$2.7M | −$1.4M | −$11.9M | −$2.5M | −$2.9M | −$2.2M | −$3.1M | −$3.3M |
| Depreciation & amortization | $1.0M | $1.3M | $1.3M | $1.2M | $1.1M | $1.0M | $1.1M | $1.1M | $1.1M | $1.5M | $944,000 | $980,000 |
| Stock-based compensation | $430,000 | $481,000 | $451,000 | $533,000 | $499,000 | $476,000 | $517,000 | $537,000 | $572,000 | $468,000 | $555,000 | $331,000 |
| Change in working capital | −$985,000 | $1.3M | −$1.2M | $1.2M | −$255,000 | −$178,000 | −$408,000 | $196,000 | $1.7M | −$2.0M | −$97,000 | −$319,000 |
| Other non-cash items | $189,000 | $188,000 | $181,000 | $207,000 | $176,000 | −$25,000 | $9.4M | −$355,000 | −$325,000 | −$126,000 | −$34,000 | $599,000 |
| Cash from operating activities | −$969,000 | $1.1M | −$1.8M | $319,000 | −$1.2M | −$54,000 | −$1.2M | −$1.1M | $126,000 | −$2.4M | −$1.8M | −$1.7M |
| Investing activities | ||||||||||||
| Capital expenditures | −$232,000 | −$191,000 | −$241,000 | −$194,000 | −$232,000 | −$12,000 | −$536,000 | −$640,000 | −$433,000 | −$490,000 | −$564,000 | −$362,000 |
| Investments (net) | −$232,000 | −$191,000 | −$241,000 | −$194,000 | −$232,000 | −$12,000 | −$536,000 | −$640,000 | −$433,000 | −$490,000 | −$564,000 | −$362,000 |
| Acquisitions & other investing | $232,000 | — | $241,000 | $194,000 | $232,000 | $12,000 | $536,000 | $640,000 | $433,000 | $490,000 | $564,000 | $362,000 |
| Cash from investing activities | −$232,000 | — | −$241,000 | −$194,000 | −$232,000 | −$12,000 | −$536,000 | −$640,000 | −$433,000 | −$490,000 | −$564,000 | −$362,000 |
| Financing activities | ||||||||||||
| Share repurchases & issuance (net) | −$33,000 | — | −$76.9M | −$77,000 | — | — | — | — | — | — | — | — |
| Net borrowing (repayment) | — | — | — | — | — | — | — | −$125,000 | −$125,000 | −$125,000 | −$125,000 | — |
| Shares issued | $0 | $0 | $0 | $0 | $100,000 | $0 | $0 | $0 | $0 | $0 | $8.3M | $0 |
| Other financing | $500,000 | $496,000 | $76.1M | −$491,000 | $2.1M | $699,000 | $231,000 | −$73,000 | −$179,000 | −$2.1M | −$76,000 | $6,000 |
| Cash from financing activities | $467,000 | $496,000 | −$783,000 | −$568,000 | $2.2M | $699,000 | $231,000 | −$198,000 | −$304,000 | −$2.2M | $8.1M | $6,000 |
| Summary | ||||||||||||
| Net change in cash | −$734,000 | $1.4M | −$2.8M | −$443,000 | $789,000 | $633,000 | −$1.5M | −$1.9M | −$611,000 | −$5.1M | $5.8M | −$2.0M |
| Cash at end of period | $1.4M | $2.2M | $754,000 | $3.5M | $4.0M | $3.2M | $2.6M | $4.1M | $6.0M | $6.6M | $11.7M | $5.9M |
| Free cash flow | −$1.2M | $933,000 | −$2.0M | $125,000 | −$1.4M | −$66,000 | −$1.8M | −$1.7M | −$307,000 | −$2.9M | −$2.3M | −$2.0M |
| Free cash flow margin | −25.0% | 20.0% | −45.2% | 2.8% | −33.0% | −1.2% | −28.7% | −29.5% | −5.8% | −43.2% | −37.5% | −34.1% |
| Capex / revenue | 4.8% | 4.1% | 5.5% | 4.3% | 5.4% | 0.2% | 8.7% | 11.1% | 8.1% | 7.3% | 9.1% | 6.0% |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
STRM cash generation
In fiscal 2025 (ended January 31, 2025), Streamline Health Solutions generated -$1.5 million of cash from operations and spent $0.9 million on capital expenditures, leaving free cash flow of -$2.4 million, −13.3% of revenue. Cash and equivalents fell by $1.0 million over the year.
Related: STRM income statement, STRM balance sheet. See the STRM stock overview for the latest quote and news.
STRM cash flow FAQ
What is Streamline Health Solutions's free cash flow?
Streamline Health Solutions's free cash flow was -$2.4 million in fiscal 2025: -$1.5 million of operating cash flow minus $0.9 million of capital expenditures It was -$3.8 million a year earlier..
How much cash does Streamline Health Solutions generate from operations?
Streamline Health Solutions generated -$1.5 million of cash from operating activities in fiscal 2025.
How much does Streamline Health Solutions spend on capital expenditures?
Streamline Health Solutions spent $0.9 million on capital expenditures in fiscal 2025, 4.8% of revenue, compared with $1.6 million the year before.